Genome-Wide Analysis of Alternative Splicing Identifies a Prognostic Signature in ER-Positive Breast Cancer
The study identified a novel five-event AS prognostic signature that significantly stratified patients into high-risk and low-risk groups for both disease-free survival and overall survival and highlights the potential of splicing-based models to refine risk stratification beyond conventional gene expression analysis.